Adipokines and obesity are associated with colorectal polyps in adult males: A cross-sectional study

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Comstock, Sarah S ^a   Hortos, Kari ^b   Kovan, Bruce ^b,c   McCaskey, Sarah ^b   Pathak, Dorothy R ^d   Fenton, Jenifer I ^a,b  

^a Michigan State University   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Tri County Gastroenterology Professional Corporation   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CAUCASIAN; COLON POLYPOSIS; COLONOSCOPY; COLORECTAL POLYP; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN BLOOD LEVEL; RISK FACTOR; TUMOR VOLUME; WAIST CIRCUMFERENCE;

ADENOMA; ADENOMATOUS POLYPS; ADIPOKINES; ADULT; AGED; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; OBESITY; WAIST CIRCUMFERENCE;

EID: 84898429070     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085939     Document Type: Article

References (70)

1. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, et al. (2004) Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291: 2847-2850. (Pubitemid 38747805)
2. Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307: 491-497.
3. Larsson SC, Wolk A (2007) Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 86: 556-565. (Pubitemid 47435820)
4. Moghaddam AA, Woodward M, Huxley R (2007) Obesity and risk of colorectal cancer: A meta-analysis of 31 studies with 70,000 events. Cancer Epidemiology Biomarkers & Prevention 16: 2533-2547. (Pubitemid 351196307)
5. Harriss DJ, Atkinson G, George K, Cable NT, Reilly T, et al. (2009) Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis 11: 547-563.
6. Ma Y, Yang Y, Wang F, Zhang P, Shi C, et al. (2013) Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One 8: e53916.
7. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, et al. (2012) Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366: 687-696.
8. Ben Q, An W, Jiang Y, Zhan X, Du Y, et al. (2012) Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology 142: 762-772.
9. Okabayashi K, Ashrafian H, Hasegawa H, Yoo JH, Patel VM, et al. (2012) Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol 107: 1175-1185; quiz 1186.
10. Omata F, Deshpande GA, Ohde S, Mine T, Fukui T (2013) The association between obesity and colorectal adenoma: systematic review and meta-analysis. Scand J Gastroenterol 48: 136-146.
11. Balistreri CR, Caruso C, Candore G (2010) The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm 2010: 802078.
12. Lyon CJ, Law RE, Hsueh WA (2003) Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144: 2195-2200. (Pubitemid 36629866)
13. Coussens LM, Zitvogel L, Palucka AK (2013) Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339: 286-291.
14. Murashima M, Hoerr SL, Hughes SO, Kattelmann KK, Phillips BW (2012) Maternal parenting behaviors during childhood relate to weight status and fruit and vegetable intake of college students. J Nutr Educ Behav 44: 556-563.
15. Yuan Y (2011) Multiple Imputation Using SAS Software. Journal of Statistical Software 45.
16. WHO (March 14, 2013) World Health Organization Global Database on BMI. 〈apps.who.int/bmi/index.jsp〉
17. Kumor A, Daniel P, Pietruczuk M, Malecka-Panas E (2009) Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis 24: 275-281.
18. Otake S, Takeda H, Suzuki Y, Fukui T, Watanabe S, et al. (2005) Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 11: 3642-3646. (Pubitemid 40685579)
19. Erarslan E, Turkay C, Koktener A, Koca C, Uz B, et al. (2009) Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia. Dig Dis Sci 54: 862-868.
20. Chia VM, Newcomb PA, Lampe JW, White E, Mandelson MT, et al. (2007) Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 16: 2697-2703. (Pubitemid 351196326)
21. Fukumoto J, Otake T, Tajima O, Tabata S, Abe H, et al. (2008) Adiponectin and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci 99: 781-786. (Pubitemid 351448083)
22. Nakajima TE, Yamada Y, Hamano T, Furuta K, Matsuda T, et al. (2010) Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci 101: 1286-1291.
23. Yamaji T, Iwasaki M, Sasazuki S, Tsugane S (2010) Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer Res 70: 5430-5437.
24. Bobe G, Murphy G, Rogers CJ, Hance KW, Albert PS, et al. (2010) Serum Adiponectin, Leptin, C-Peptide, Homocysteine, and Colorectal Adenoma Recurrence in the Polyp Prevention Trial. Cancer Epidemiology Biomarkers & Prevention 19: 1441-1452.
25. Wernli KJ, Newcomb PA, Wang Y, Makar KW, Shadman M, et al. (2010) Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps. Growth Horm IGF Res 20: 305-309.
26. Lieberman DA, Prindiville S, Weiss DG, Willett W (2003) Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 290: 2959-2967. (Pubitemid 37505528)
27. Fu Z, Shrubsole MJ, Smalley WE, Wu H, Chen Z, et al. (2012) Lifestyle factors and their combined impact on the risk of colorectal polyps. Am J Epidemiol 176: 766-776.
28. Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CJ, et al. (2002) Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomarkers Prev 11: 1012-1018. (Pubitemid 35192651)
29. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, et al. (2012) Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143: 844-857.
30. Kahi CJ, Anderson JC, Rex DK (2013) Screening and surveillance for colorectal cancer: state of the art. Gastrointest Endosc 77: 335-350.
31. Odze RD, Maley CC (2010) Neoplasia without dysplasia: lessons from Barrett esophagus and other tubal gut neoplasms. Arch Pathol Lab Med 134: 896-906.
32. Noffsinger AE (2009) Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol 4: 343-364.
33. Makkar R, Pai RK, Burke CA (2012) Sessile serrated polyps: cancer risk and appropriate surveillance. Cleve Clin J Med 79: 865-871.
34. Il'yasova D, Colbert LH, Harris TB, Newman AB, Bauer DC, et al. (2005) Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 14: 2413- 2418.
35. Heikkila K, Harris R, Lowe G, Rumley A, Yarnell J, et al. (2009) Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 20: 15-26.
36. Sasaki Y, Takeda H, Sato T, Orii T, Nishise S, et al. (2012) Serum Interleukin-6, insulin, and HOMA-IR in male individuals with colorectal adenoma. Clin Cancer Res 18: 392-399.
37. Groblewska M, Mroczko B, Wereszczynska-Siemiatkowska U, Kedra B, Lukaszewicz M, et al. (2008) Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients. Clin Chem Lab Med 46: 1423-1428.
38. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, et al. (2003) Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 278: 9073-9085. (Pubitemid 36800387)
39. Dalamaga M, Diakopoulos KN, Mantzoros CS (2012) The role of adiponectin in cancer: a review of current evidence. Endocr Rev 33: 547-594.
40. Tilg H, Wolf AM (2005) Adiponectin: a key fat-derived molecule regulating inflammation. Expert Opin Ther Targets 9: 245-251. (Pubitemid 40613866)
41. Bottner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, et al. (2004) Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 89: 4053-4061. (Pubitemid 39071513)
42. Koerner A, Kratzsch J, Kiess W (2005) Adipocytokines: leptin-the classical, resistin-the controversical, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19: 525-546.
43. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS (2005) Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 97: 1688-1694. (Pubitemid 41672235)
44. Wang W, Yang P, Zhong Y, Zhao Z, Xing L, et al. (2013) Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury. Cell Res.
45. Wan M, Li Y, Xue H, Li Q, Li J (2006) TNF-alpha induces Lnk expression through PI3K-dependent signaling pathway in human umbilical vein endothelial cells. J Surg Res 136: 53-57. (Pubitemid 44634567)
46. Sweeney G (2002) Leptin signalling. Cell Signal 14: 655-663.
47. Huang XF, Chen JZ (2009) Obesity, the PI3K/Akt signal pathway and colon cancer. Obes Rev 10: 610-616.
48. Zhang J, Roberts TM, Shivdasani RA (2011) Targeting PI3K signaling as a therapeutic approach for colorectal cancer. Gastroenterology 141: 50-61.
49. Dreesen O, Brivanlou AH (2007) Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev 3: 7-17. (Pubitemid 47472808)
50. Parsons DW, Wang TL, Samuels Y, Bardelli A, Cummins JM, et al. (2005) Colorectal cancer: mutations in a signalling pathway. Nature 436: 792. (Pubitemid 41160630)
51. Liu M, Guo S, Stiles JK (2011) The emerging role of CXCL10 in cancer (Review). Oncol Lett 2: 583-589.
52. Herder C, Hauner H, Kempf K, Kolb H, Skurk T (2007) Constitutive and regulated expression and secretion of interferon-gamma-inducible protein 10 (IP-10/CXCL10) in human adipocytes. Int J Obes (Lond) 31: 403-410.
53. Herder C, Schneitler S, Rathmann W, Haastert B, Schneitler H, et al. (2007) Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab 92: 4569-4574. (Pubitemid 350223428)
54. Toiyama Y, Fujikawa H, Kawamura M, Matsushita K, Saigusa S, et al. (2012) Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer. Int J Oncol 40: 560-566.
55. Jiang Z, Xu Y, Cai S (2010) CXCL10 expression and prognostic significance in stage II and III colorectal cancer. Mol Biol Rep 37: 3029-3036.
56. Mlecnik B, Tosolini M, Charoentong P, Kirilovsky A, Bindea G, et al. (2010) Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology 138: 1429-1440.
57. Yang X, Chu Y, Wang Y, Zhang R, Xiong S (2006) Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity. J Leukoc Biol 80: 1434-1444. (Pubitemid 44904982)
58. Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9: 361-371.
59. Kang M, Edmundson P, Araujo-Perez F, McCoy AN, Galanko J, et al. (2013) Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas. BMC Cancer 13: 91.
60. Sandhofer A, Laimer M, Ebenbichler CF, Kaser S, Paulweber B, et al. (2003) Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome. Obes Res 11: 760-768. (Pubitemid 41151602)
61. Zhang Y, McCormick LL, Gilliam AC (2003) Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. J Invest Dermatol 121: 713-719. (Pubitemid 37239112)
62. Otero M, Lago R, Gomez R, Dieguez C, Lago F, et al. (2006) Towards a proinflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 45: 944-950. (Pubitemid 44283047)
63. Endo H, Hosono K, Uchiyama T, Sakai E, Sugiyama M, et al. (2011) Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut 60: 1363-1371.
64. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
65. Fenton JI, McCaskey SJ, Woodworth HL (2010) Molecular Mechanisms of Obesity, Inflammation and Cancer: The Use of in vitro Model Approaches for Targeted Prevention Strategies. Open Obesity Journal 2: 23-37.
66. Birmingham JM, Busik JV, Hansen-Smith FM, Fenton JI (2009) Novel mechanism for obesity-induced colon cancer progression. Carcinogenesis.
67. Fenton JI, Hord NG, Lavigne JA, Perkins SN, Hursting SD (2005) Leptin, insulin-like growth factor-1, and insulin-like growth factor-2 are mitogens in ApcMin/+ but not Apc+/+ colonic epithelial cell lines. Cancer Epidemiol Biomarkers Prev 14: 1646-1652. (Pubitemid 40995074)
68. Fenton JI, Hursting SD, Perkins SN, Hord NG (2006) Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc (Min/+) colon epithelial cell line. Carcinogenesis 27: 1507-1515. (Pubitemid 43994862)
69. Fenton JI, Lavigne JA, Perkins SN, Liu H, Chandramouli GV, et al. (2008) Microarray analysis reveals that leptin induces autocrine/paracrine cascades to promote survival and proliferation of colon epithelial cells in an Apc genotype-dependent fashion. Mol Carcinog 47: 9-21.
70. Hardwick JCH, Van den Brink GR, Offerhaus GJ, Van Deventer SJH, Peppelenbosch MP (2001) Leptin is a growth factor for colonic epithelial cells. Gastroenterology 121: 79-90. (Pubitemid 32591517)